Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPci-pal Regulatory News (PCIP)

Share Price Information for Pci-pal (PCIP)

Share Price is delayed by 15 minutes
Get Live Data
49.00    0.00 (0.00%)
Bid:
48.00
Ask:
50.00
Spread: 2.00 (4.167%)
Market Cap: £35.50m
PCIP Live PriceLast checked at - London Stock Exchange

Intraday Pci-pal Share Chart

Grant of Options under Long-Term Incentive Plan

18 Dec 2025 16:44

RNS Number : 1839M
PCI-PAL PLC
18 December 2025
 

18 December 2025

 

PCI-PAL PLC

("PCI Pal", the "Company" or "the Group")

 

Grant of Options under Long-Term Incentive Plan

 

PCI-PAL PLC (AIM: PCIP), the global cloud provider of secure payment solutions for business communications, announces that following shareholders voting in favour of the new Long-Term Incentive Plan at the Company's AGM held on 1 December 2025, the remuneration committee has on 18 December 2025 granted options (the "Options") over ordinary shares of nominal value each in the Company (the "Ordinary Shares") to certain persons discharging managerial responsibilities ("PDMRs"), as set out in the table below.

 

The Board recognises the importance of equity incentive schemes as a means to incentivise and retain executive directors, ensuring alignment with the objectives of the Company and its shareholders. Awards are structured as nominal-cost share options subject to the achievement of performance conditions (the "LTIP Awards").

 

The Remuneration Committee of the Board approved the grants to the Executive Directors on 18 December 2025 as follows:

 

PDMR

Position

Options

James Barham

CEO

1,000,000

Ryan Murray

CFO

479,499

Total

1,479,499

 

The LTIP Awards will normally vest on the third anniversary of grant, subject to continued employment and the satisfaction of performance conditions based on (i) share price targets (75% of the LTIP Awards) and (ii) earnings targets (25% of the LTIP Awards), in each case on a sliding scale. The performance targets will be as follows:

 

% Vesting of each part of an award

Share Price Targets*

(75% of Initial Awards)

EBITDA Targets**

(25% of Initial Awards)

0% vesting

Below or Equal to 75p

Below or Equal to £6m

Pro-rata between 0% and 100%

Between 75p and 130p

Between £6m and £8m

100% vesting

Equal to or more than 130p

Equal to or more than £8m

*Based on the average share price in the final 3 months of the 3 yr performance period ending on the 3rd anniversary of grant

** Based on Adjusted EBITDA for FY2028

 

Following the grant of the Options, the total number of Ordinary Shares subject to outstanding options is 11,247,471 Ordinary Shares, representing approximately 15.5% of the Company's current issued share capital.

 

For further information, please contact:

 

PCI-PAL PLC

Via Walbrook PR

James Barham - Chief Executive Officer

Ryan Murray - Chief Financial Officer

 

Cavendish Capital Markets Limited (Nominated Adviser and Broker)

+44 (0) 20 7227 0500

Marc Milmo/Fergus Sullivan/Finn Gordon (Corporate Finance)

Sunila De Silva (Corporate Broking)

 

Walbrook PR

+44 (0) 20 7933 8780

Tom Cooper/Nick Rome

+44 (0) 797 122 1972

tom.cooper@walbrookpr.com

About PCI Pal:

 

PCI Pal is a leading provider of Software-as-a-Service ("SaaS") solutions that empower companies to take payments from their customers securely, adhere to strict industry governance, and remove their business from the significant risks posed by non-compliance and data loss. Our products secure payments and data in any business communications environment including voice, chat, social, email, and contact centre. We are integrated to, and resold by, some of the worlds' leading business communications vendors, as well as major payment service providers.

 

The entirety of our product-base is available from our global cloud platform hosted in Amazon Web Services ("AWS"), with regional instances across EMEA, North America, and ANZ.

 

For more information visit www.pcipal.com or follow the team on Linkedin: https://www.linkedin.com/company/pci-pal/

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

James Barham

2.

Reason for the notification

a)

Position/status:

PDMR - Chief Executive Officer

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

PCI-PAL PLC

b)

LEI:

213800XTX34IQYMYES95

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Options over Ordinary Shares of 1 pence each

 

ISIN Code: GB0009737155

b)

Nature of the transaction:

Grant of Options

c)

Price(s) and volume(s):

Price(s)

Volume(s)

1 pence

1,000,000

d)

Aggregated information:

· Aggregated volume:

· Price:

See 4(c) above

 

e)

Dates of the transactions:

18 December 2025

f)

Place of the transaction:

Off Market Transaction

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Ryan Murray

2.

Reason for the notification

a)

Position/status:

PDMR - Chief Financial Officer

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

PCI-PAL PLC

b)

LEI:

213800XTX34IQYMYES95

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Options over Ordinary Shares of 1 pence each

 

ISIN Code: GB0009737155

b)

Nature of the transaction:

Grant of Options

c)

Price(s) and volume(s):

Price(s)

Volume(s)

1 pence

479,499

d)

Aggregated information:

· Aggregated volume:

· Price:

See 4(c) above

 

e)

Dates of the transactions:

18 December 2025

f)

Place of the transaction:

Off Market Transaction

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAKAPFLESFFA
Date   Source Headline
14th Apr 20267:00 amRNS-RHIPAA, HITRUST & SOC 2 Type II certification
18th Mar 20267:00 amRNS-RMajor New Reseller Partnership with Global Telco
10th Mar 20263:07 pmRNSHolding(s) in Company
10th Mar 20263:07 pmRNSHolding(s) in Company
3rd Mar 20267:00 amRNSInterim Results, Analyst Briefing & Investor Pres
23rd Feb 20267:00 amRNS-RNew Major Strategic Reseller Partnership
17th Feb 20267:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
10th Feb 20265:07 pmRNSHolding(s) in Company
6th Feb 202611:26 amRNSHolding(s) in Company
6th Feb 202611:25 amRNSHolding(s) in Company
5th Feb 202612:48 pmRNSHolding(s) in Company
3rd Feb 20267:00 amRNSTrading Update
18th Dec 20254:44 pmRNSGrant of Options under Long-Term Incentive Plan
18th Dec 20254:44 pmRNSGrant of Options under Long-Term Incentive Plan
1st Dec 20252:49 pmRNSResult of AGM
19th Nov 20257:00 amRNS-RStrategic US Healthcare Sector Integration
17th Nov 20253:19 pmRNS-RCMD Presentation Video
14th Nov 20257:00 amRNS-RCMD Presentation & MelloLondon
11th Nov 20257:00 amRNSCapital Markets Day
6th Nov 20254:20 pmRNSAnnual Financial Report & Notice of AGM
25th Sep 20258:45 amRNSHolding(s) in Company
9th Sep 20257:00 amRNSFinal Results, Analyst Briefing & Investor Pres
19th Aug 20257:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
30th Jul 20253:18 pmRNSDirector Share Purchases
29th Jul 202510:20 amRNSDirector Share Purchase
29th Jul 20257:01 amRNSTrading & Business Update
29th Jul 20257:00 amRNSNew Product Launch
1st Jul 20257:00 amRNSBoard Changes
20th Jun 202512:00 pmRNSIssue of Equity & TVR
3rd Apr 20259:24 amRNSHolding(s) in Company
12th Mar 20253:20 pmRNSDirector Share Purchases
10th Mar 20257:00 amRNS-RPCI Pal and RingCentral Inc Partnership
6th Mar 20252:00 pmRNSPDMR Issue of Options
4th Mar 20253:49 pmRNSDirector Share Purchase
4th Mar 20257:00 amRNSInterim Results, Analyst Briefing & Investor Pres
18th Feb 20257:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
27th Jan 20257:00 amRNSTrading Update
11th Dec 20242:42 pmRNSHolding(s) in Company
11th Dec 20242:17 pmRNSResult of AGM
11th Dec 20247:00 amRNSAGM Statement
6th Dec 20244:10 pmRNSExercise of Options & TVR
14th Nov 20244:23 pmRNSAnnual Financial Report & Notice of AGM
22nd Oct 20247:00 amRNSFinal Results, Analyst Briefing & Investor Pres
14th Oct 20247:00 amRNSConfirmation of CFO Appointment
19th Sep 20247:00 amRNSAudit Update & Timing of Results
10th Sep 20244:46 pmRNSHolding(s) in Company
28th Aug 20247:00 amRNSTrading Update, New Partner & Notice of Results
22nd Jul 20249:15 amRNSHolding(s) in Company
1st Jul 20245:23 pmRNSExercise of Options, Director Shareholding & TVR
1st Jul 20247:00 amRNSBoard Changes - Appointment of CFO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.